HEADER OXIDOREDUCTASE 02-MAY-23 8SPD TITLE CYTOCHROME P450 (CYP) 3A4 CRYSTALLIZED WITH CLOTRIMAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 3A4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 1,4-CINEOLE 2-EXO-MONOOXYGENASE,8-CINEOLE 2-EXO- COMPND 5 MONOOXYGENASE,ALBENDAZOLE MONOOXYGENASE (SULFOXIDE-FORMING), COMPND 6 ALBENDAZOLE SULFOXIDASE,CYPIIIA3,CYPIIIA4,CHOLESTEROL 25-HYDROXYLASE, COMPND 7 CYTOCHROME P450 3A3,CYTOCHROME P450 HLP,CYTOCHROME P450 NF-25, COMPND 8 CYTOCHROME P450-PCN1,NIFEDIPINE OXIDASE,QUININE 3-MONOOXYGENASE; COMPND 9 EC: 1.14.14.1,1.14.14.56,1.14.14.73,1.14.14.55; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYP3A4, CYP3A3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSE3A4DH KEYWDS INHIBITOR, COMPLEX, CYP, CYTOCHROME P450, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.H.HSU,E.F.JOHNSON REVDAT 2 22-NOV-23 8SPD 1 JRNL REVDAT 1 11-OCT-23 8SPD 0 JRNL AUTH M.H.HSU,E.F.JOHNSON JRNL TITL DIFFERENTIAL EFFECTS OF CLOTRIMAZOLE ON X-RAY CRYSTAL JRNL TITL 2 STRUCTURES OF HUMAN CYTOCHROMES P450 3A5 AND 3A4. JRNL REF DRUG METAB.DISPOS. V. 51 1642 2023 JRNL REFN ESSN 1521-009X JRNL PMID 37770228 JRNL DOI 10.1124/DMD.123.001464 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.910 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 21098 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.5500 - 5.5400 1.00 2866 164 0.1742 0.2551 REMARK 3 2 5.5400 - 4.4000 1.00 2877 147 0.2091 0.2121 REMARK 3 3 4.4000 - 3.8500 1.00 2900 139 0.2259 0.2781 REMARK 3 4 3.8500 - 3.4900 1.00 2882 140 0.2738 0.2903 REMARK 3 5 3.4900 - 3.2400 1.00 2886 146 0.3003 0.3811 REMARK 3 6 3.2400 - 3.0500 1.00 2882 138 0.3463 0.3664 REMARK 3 7 3.0500 - 2.9000 0.97 2763 168 0.4091 0.4218 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.637 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.747 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 114.5 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 130.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3613 REMARK 3 ANGLE : 0.526 4935 REMARK 3 CHIRALITY : 0.040 562 REMARK 3 PLANARITY : 0.004 652 REMARK 3 DIHEDRAL : 9.280 1334 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND ( RESID 28:496 OR RESID 601:602 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): 19.068 27.274 13.276 REMARK 3 T TENSOR REMARK 3 T11: 0.8473 T22: 0.9442 REMARK 3 T33: 0.6447 T12: 0.0899 REMARK 3 T13: -0.0163 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 3.3723 L22: 5.5701 REMARK 3 L33: 2.9637 L12: 1.2624 REMARK 3 L13: 0.3844 L23: -0.2392 REMARK 3 S TENSOR REMARK 3 S11: 0.0467 S12: -0.1748 S13: -0.1933 REMARK 3 S21: -0.5625 S22: -0.0258 S23: 0.0508 REMARK 3 S31: 0.4907 S32: 0.3166 S33: -0.0161 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANOMALOUS PAIRS |F(+)| AND |F(-)| WERE REMARK 3 USED SEPARATELY FOR REFINEMENT NUMBERING 21098. REMARK 4 REMARK 4 8SPD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000273745. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21098 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 39.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 11.10 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEF 3350, HEPES, LITHIUM SULFATE, REMARK 280 SODIUM CHLORIDE, PH 7.4, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.58900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.89600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 62.84550 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.58900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.89600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 62.84550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.58900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.89600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 62.84550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.58900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.89600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 62.84550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 22 REMARK 465 ALA A 23 REMARK 465 LEU A 24 REMARK 465 TYR A 25 REMARK 465 GLY A 26 REMARK 465 THR A 27 REMARK 465 LEU A 261 REMARK 465 GLU A 262 REMARK 465 ASP A 263 REMARK 465 THR A 264 REMARK 465 GLN A 265 REMARK 465 LYS A 266 REMARK 465 HIS A 267 REMARK 465 ARG A 268 REMARK 465 VAL A 269 REMARK 465 LYS A 282 REMARK 465 GLU A 283 REMARK 465 THR A 284 REMARK 465 GLU A 285 REMARK 465 SER A 286 REMARK 465 HIS A 287 REMARK 465 ASP A 497 REMARK 465 GLY A 498 REMARK 465 THR A 499 REMARK 465 VAL A 500 REMARK 465 SER A 501 REMARK 465 GLY A 502 REMARK 465 ALA A 503 REMARK 465 HIS A 504 REMARK 465 HIS A 505 REMARK 465 HIS A 506 REMARK 465 HIS A 507 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 28 CG ND1 CD2 CE1 NE2 REMARK 470 PHE A 108 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 127 CG CD CE NZ REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 ARG A 162 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 LEU A 196 CG CD1 CD2 REMARK 470 ASN A 197 CG OD1 ND2 REMARK 470 GLN A 200 CG CD OE1 NE2 REMARK 470 PHE A 203 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 205 CG CD OE1 OE2 REMARK 470 ASN A 206 CG OD1 ND2 REMARK 470 LYS A 208 CG CD CE NZ REMARK 470 LYS A 209 CG CD CE NZ REMARK 470 ARG A 212 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 213 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 214 CG OD1 OD2 REMARK 470 PHE A 215 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 216 CG CD1 CD2 REMARK 470 PHE A 219 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 221 CG CD1 CD2 REMARK 470 PHE A 228 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 236 CG CD1 CD2 REMARK 470 ASN A 237 CG OD1 ND2 REMARK 470 PHE A 241 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 243 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 244 CG CD OE1 OE2 REMARK 470 LEU A 249 CG CD1 CD2 REMARK 470 ARG A 250 CG CD NE CZ NH1 NH2 REMARK 470 SER A 252 OG REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 255 CG CD NE CZ NH1 NH2 REMARK 470 MET A 256 CG SD CE REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 GLU A 258 CG CD OE1 OE2 REMARK 470 ARG A 260 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 270 CG OD1 OD2 REMARK 470 LEU A 295 CG CD1 CD2 REMARK 470 ASN A 341 CG OD1 ND2 REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 LYS A 378 CG CD CE NZ REMARK 470 LYS A 379 CG CD CE NZ REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 LYS A 469 CG CD CE NZ REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 492 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 85 -30.53 -135.13 REMARK 500 VAL A 95 -62.22 -107.77 REMARK 500 GLU A 97 40.96 -96.70 REMARK 500 VAL A 101 -66.71 -106.47 REMARK 500 PHE A 108 -169.03 -75.80 REMARK 500 PRO A 110 97.53 -68.09 REMARK 500 ASP A 123 -130.83 59.96 REMARK 500 PHE A 137 61.50 -105.60 REMARK 500 PHE A 189 -0.60 -142.40 REMARK 500 ASP A 194 -127.05 58.41 REMARK 500 ASN A 198 -47.42 -134.04 REMARK 500 LEU A 216 -76.80 58.49 REMARK 500 PHE A 219 -57.23 71.67 REMARK 500 ALA A 289 -169.88 58.16 REMARK 500 TYR A 307 -85.60 -86.00 REMARK 500 HIS A 324 79.40 -116.82 REMARK 500 MET A 371 -46.90 65.84 REMARK 500 ARG A 440 56.56 -103.89 REMARK 500 CYS A 468 -168.02 -109.05 REMARK 500 LEU A 483 87.68 57.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 442 SG REMARK 620 2 HEM A 601 NA 95.1 REMARK 620 3 HEM A 601 NB 78.9 87.4 REMARK 620 4 HEM A 601 NC 88.9 171.9 86.5 REMARK 620 5 HEM A 601 ND 104.3 93.5 176.5 92.3 REMARK 620 6 CL6 A 602 NAN 156.0 77.4 78.0 96.2 99.0 REMARK 620 N 1 2 3 4 5 DBREF 8SPD A 24 503 UNP P08684 CP3A4_HUMAN 24 503 SEQADV 8SPD MET A 22 UNP P08684 INITIATING METHIONINE SEQADV 8SPD ALA A 23 UNP P08684 EXPRESSION TAG SEQADV 8SPD HIS A 504 UNP P08684 EXPRESSION TAG SEQADV 8SPD HIS A 505 UNP P08684 EXPRESSION TAG SEQADV 8SPD HIS A 506 UNP P08684 EXPRESSION TAG SEQADV 8SPD HIS A 507 UNP P08684 EXPRESSION TAG SEQRES 1 A 486 MET ALA LEU TYR GLY THR HIS SER HIS GLY LEU PHE LYS SEQRES 2 A 486 LYS LEU GLY ILE PRO GLY PRO THR PRO LEU PRO PHE LEU SEQRES 3 A 486 GLY ASN ILE LEU SER TYR HIS LYS GLY PHE CYS MET PHE SEQRES 4 A 486 ASP MET GLU CYS HIS LYS LYS TYR GLY LYS VAL TRP GLY SEQRES 5 A 486 PHE TYR ASP GLY GLN GLN PRO VAL LEU ALA ILE THR ASP SEQRES 6 A 486 PRO ASP MET ILE LYS THR VAL LEU VAL LYS GLU CYS TYR SEQRES 7 A 486 SER VAL PHE THR ASN ARG ARG PRO PHE GLY PRO VAL GLY SEQRES 8 A 486 PHE MET LYS SER ALA ILE SER ILE ALA GLU ASP GLU GLU SEQRES 9 A 486 TRP LYS ARG LEU ARG SER LEU LEU SER PRO THR PHE THR SEQRES 10 A 486 SER GLY LYS LEU LYS GLU MET VAL PRO ILE ILE ALA GLN SEQRES 11 A 486 TYR GLY ASP VAL LEU VAL ARG ASN LEU ARG ARG GLU ALA SEQRES 12 A 486 GLU THR GLY LYS PRO VAL THR LEU LYS ASP VAL PHE GLY SEQRES 13 A 486 ALA TYR SER MET ASP VAL ILE THR SER THR SER PHE GLY SEQRES 14 A 486 VAL ASN ILE ASP SER LEU ASN ASN PRO GLN ASP PRO PHE SEQRES 15 A 486 VAL GLU ASN THR LYS LYS LEU LEU ARG PHE ASP PHE LEU SEQRES 16 A 486 ASP PRO PHE PHE LEU SER ILE THR VAL PHE PRO PHE LEU SEQRES 17 A 486 ILE PRO ILE LEU GLU VAL LEU ASN ILE CYS VAL PHE PRO SEQRES 18 A 486 ARG GLU VAL THR ASN PHE LEU ARG LYS SER VAL LYS ARG SEQRES 19 A 486 MET LYS GLU SER ARG LEU GLU ASP THR GLN LYS HIS ARG SEQRES 20 A 486 VAL ASP PHE LEU GLN LEU MET ILE ASP SER GLN ASN SER SEQRES 21 A 486 LYS GLU THR GLU SER HIS LYS ALA LEU SER ASP LEU GLU SEQRES 22 A 486 LEU VAL ALA GLN SER ILE ILE PHE ILE PHE ALA GLY TYR SEQRES 23 A 486 GLU THR THR SER SER VAL LEU SER PHE ILE MET TYR GLU SEQRES 24 A 486 LEU ALA THR HIS PRO ASP VAL GLN GLN LYS LEU GLN GLU SEQRES 25 A 486 GLU ILE ASP ALA VAL LEU PRO ASN LYS ALA PRO PRO THR SEQRES 26 A 486 TYR ASP THR VAL LEU GLN MET GLU TYR LEU ASP MET VAL SEQRES 27 A 486 VAL ASN GLU THR LEU ARG LEU PHE PRO ILE ALA MET ARG SEQRES 28 A 486 LEU GLU ARG VAL CYS LYS LYS ASP VAL GLU ILE ASN GLY SEQRES 29 A 486 MET PHE ILE PRO LYS GLY VAL VAL VAL MET ILE PRO SER SEQRES 30 A 486 TYR ALA LEU HIS ARG ASP PRO LYS TYR TRP THR GLU PRO SEQRES 31 A 486 GLU LYS PHE LEU PRO GLU ARG PHE SER LYS LYS ASN LYS SEQRES 32 A 486 ASP ASN ILE ASP PRO TYR ILE TYR THR PRO PHE GLY SER SEQRES 33 A 486 GLY PRO ARG ASN CYS ILE GLY MET ARG PHE ALA LEU MET SEQRES 34 A 486 ASN MET LYS LEU ALA LEU ILE ARG VAL LEU GLN ASN PHE SEQRES 35 A 486 SER PHE LYS PRO CYS LYS GLU THR GLN ILE PRO LEU LYS SEQRES 36 A 486 LEU SER LEU GLY GLY LEU LEU GLN PRO GLU LYS PRO VAL SEQRES 37 A 486 VAL LEU LYS VAL GLU SER ARG ASP GLY THR VAL SER GLY SEQRES 38 A 486 ALA HIS HIS HIS HIS HET HEM A 601 43 HET CL6 A 602 25 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CL6 1-[(2-CHLOROPHENYL)(DIPHENYL)METHYL]-1H-IMIDAZOLE HETSYN HEM HEME HETSYN CL6 CLOTRIMAZOLE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 CL6 C22 H17 CL N2 HELIX 1 AA1 GLY A 31 LEU A 36 1 6 HELIX 2 AA2 ASN A 49 LYS A 55 5 7 HELIX 3 AA3 GLY A 56 GLY A 69 1 14 HELIX 4 AA4 ASP A 86 VAL A 95 1 10 HELIX 5 AA5 VAL A 111 ALA A 117 5 7 HELIX 6 AA6 GLU A 122 SER A 134 1 13 HELIX 7 AA7 PRO A 135 THR A 138 5 4 HELIX 8 AA8 MET A 145 THR A 166 1 22 HELIX 9 AA9 LEU A 172 GLY A 190 1 19 HELIX 10 AB1 ASP A 201 LEU A 211 1 11 HELIX 11 AB2 LEU A 216 PHE A 226 1 11 HELIX 12 AB3 LEU A 229 VAL A 235 1 7 HELIX 13 AB4 PRO A 242 ARG A 260 1 19 HELIX 14 AB5 PHE A 271 ASN A 280 1 10 HELIX 15 AB6 SER A 291 TYR A 307 1 17 HELIX 16 AB7 TYR A 307 HIS A 324 1 18 HELIX 17 AB8 HIS A 324 LEU A 339 1 16 HELIX 18 AB9 THR A 346 LEU A 351 1 6 HELIX 19 AC1 MET A 353 PHE A 367 1 15 HELIX 20 AC2 SER A 398 ARG A 403 1 6 HELIX 21 AC3 LEU A 415 LYS A 424 5 10 HELIX 22 AC4 GLY A 444 GLN A 461 1 18 SHEET 1 AA1 4 TRP A 72 ASP A 76 0 SHEET 2 AA1 4 GLN A 79 ALA A 83 -1 O VAL A 81 N PHE A 74 SHEET 3 AA1 4 VAL A 393 PRO A 397 1 O VAL A 393 N LEU A 82 SHEET 4 AA1 4 ARG A 372 VAL A 376 -1 N ARG A 375 O VAL A 394 SHEET 1 AA2 3 VAL A 170 THR A 171 0 SHEET 2 AA2 3 VAL A 490 GLU A 494 -1 O LEU A 491 N VAL A 170 SHEET 3 AA2 3 SER A 464 PRO A 467 -1 N LYS A 466 O LYS A 492 SHEET 1 AA3 2 VAL A 381 GLU A 382 0 SHEET 2 AA3 2 PHE A 387 ILE A 388 -1 O ILE A 388 N VAL A 381 LINK SG CYS A 442 FE HEM A 601 1555 1555 2.19 LINK FE HEM A 601 NAN CL6 A 602 1555 1555 1.94 CISPEP 1 ILE A 473 PRO A 474 0 -1.97 CRYST1 77.178 101.792 125.691 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012957 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009824 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007956 0.00000